| Dr Melissa Ortega Nikolaidis, MD | |
|
17207 Kuykendahl Rd, Suite 200, Spring, TX 77379-8423 | |
| (832) 698-5168 | |
| Not Available |
| Full Name | Dr Melissa Ortega Nikolaidis |
|---|---|
| Gender | Female |
| Speciality | Anesthesiology |
| Experience | 17 Years |
| Location | 17207 Kuykendahl Rd, Spring, Texas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205078433 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | N9616 (Texas) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Baylor College Of Medicine | 8224941265 | 684 |
News Archive
The Coalition for Pulmonary Fibrosis, The Pulmonary Fibrosis Foundation and the Pulmonary Fibrosis Association of Texas today announced the launch of a special, grassroots campaign to build increased national awareness of Pulmonary Fibrosis.
Transition Therapeutics Inc. announced today that the first patient has been dosed with drug candidate TT-301 in a Phase 1 clinical study. TT-301 is a small molecule compound that has demonstrated efficacy in preclinical models of rheumatoid arthritis, intracerebral haemorrhage and traumatic brain injury.
Healthcare educators and practitioners seeking guidelines, best practices, and recommendations for creating and managing cost-effective, researched-based simulation education and training programs now have a world class road map in the new textbook Defining Excellence in Simulation Programs.
The United Nations World Food Programme will phase out food aid and HIV/AIDS support to Uganda, a United Nations official said on Thursday, Xinhua/ChinaView.cn.com reports. The plan could affect more than 1.5 million people.
David Griggs, Ph.D., director of biology at Saint Louis University's Center for World Health & Medicine, has received a $1 million R01 grant from the National Institutes of Health to investigate the development of what could be a new class of drugs to treat bone diseases.
› Verified 2 days ago
| Entity Name | Baylor College Of Medicine |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053352914 PECOS PAC ID: 8224941265 Enrollment ID: O20031106000562 |
News Archive
The Coalition for Pulmonary Fibrosis, The Pulmonary Fibrosis Foundation and the Pulmonary Fibrosis Association of Texas today announced the launch of a special, grassroots campaign to build increased national awareness of Pulmonary Fibrosis.
Transition Therapeutics Inc. announced today that the first patient has been dosed with drug candidate TT-301 in a Phase 1 clinical study. TT-301 is a small molecule compound that has demonstrated efficacy in preclinical models of rheumatoid arthritis, intracerebral haemorrhage and traumatic brain injury.
Healthcare educators and practitioners seeking guidelines, best practices, and recommendations for creating and managing cost-effective, researched-based simulation education and training programs now have a world class road map in the new textbook Defining Excellence in Simulation Programs.
The United Nations World Food Programme will phase out food aid and HIV/AIDS support to Uganda, a United Nations official said on Thursday, Xinhua/ChinaView.cn.com reports. The plan could affect more than 1.5 million people.
David Griggs, Ph.D., director of biology at Saint Louis University's Center for World Health & Medicine, has received a $1 million R01 grant from the National Institutes of Health to investigate the development of what could be a new class of drugs to treat bone diseases.
› Verified 2 days ago
| Entity Name | Northwest Anesthesiology & Pain Services, P.a. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629027511 PECOS PAC ID: 9638067408 Enrollment ID: O20040304001244 |
News Archive
The Coalition for Pulmonary Fibrosis, The Pulmonary Fibrosis Foundation and the Pulmonary Fibrosis Association of Texas today announced the launch of a special, grassroots campaign to build increased national awareness of Pulmonary Fibrosis.
Transition Therapeutics Inc. announced today that the first patient has been dosed with drug candidate TT-301 in a Phase 1 clinical study. TT-301 is a small molecule compound that has demonstrated efficacy in preclinical models of rheumatoid arthritis, intracerebral haemorrhage and traumatic brain injury.
Healthcare educators and practitioners seeking guidelines, best practices, and recommendations for creating and managing cost-effective, researched-based simulation education and training programs now have a world class road map in the new textbook Defining Excellence in Simulation Programs.
The United Nations World Food Programme will phase out food aid and HIV/AIDS support to Uganda, a United Nations official said on Thursday, Xinhua/ChinaView.cn.com reports. The plan could affect more than 1.5 million people.
David Griggs, Ph.D., director of biology at Saint Louis University's Center for World Health & Medicine, has received a $1 million R01 grant from the National Institutes of Health to investigate the development of what could be a new class of drugs to treat bone diseases.
› Verified 2 days ago
| Entity Name | Best Choice Anesthesia & Pain Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1699015628 PECOS PAC ID: 5496994626 Enrollment ID: O20130620000143 |
News Archive
The Coalition for Pulmonary Fibrosis, The Pulmonary Fibrosis Foundation and the Pulmonary Fibrosis Association of Texas today announced the launch of a special, grassroots campaign to build increased national awareness of Pulmonary Fibrosis.
Transition Therapeutics Inc. announced today that the first patient has been dosed with drug candidate TT-301 in a Phase 1 clinical study. TT-301 is a small molecule compound that has demonstrated efficacy in preclinical models of rheumatoid arthritis, intracerebral haemorrhage and traumatic brain injury.
Healthcare educators and practitioners seeking guidelines, best practices, and recommendations for creating and managing cost-effective, researched-based simulation education and training programs now have a world class road map in the new textbook Defining Excellence in Simulation Programs.
The United Nations World Food Programme will phase out food aid and HIV/AIDS support to Uganda, a United Nations official said on Thursday, Xinhua/ChinaView.cn.com reports. The plan could affect more than 1.5 million people.
David Griggs, Ph.D., director of biology at Saint Louis University's Center for World Health & Medicine, has received a $1 million R01 grant from the National Institutes of Health to investigate the development of what could be a new class of drugs to treat bone diseases.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Melissa Ortega Nikolaidis, MD 2230 Mcclendon St, Houston, TX 77030-2020 Ph: (281) 236-3724 | Dr Melissa Ortega Nikolaidis, MD 17207 Kuykendahl Rd, Suite 200, Spring, TX 77379-8423 Ph: (832) 698-5168 |
News Archive
The Coalition for Pulmonary Fibrosis, The Pulmonary Fibrosis Foundation and the Pulmonary Fibrosis Association of Texas today announced the launch of a special, grassroots campaign to build increased national awareness of Pulmonary Fibrosis.
Transition Therapeutics Inc. announced today that the first patient has been dosed with drug candidate TT-301 in a Phase 1 clinical study. TT-301 is a small molecule compound that has demonstrated efficacy in preclinical models of rheumatoid arthritis, intracerebral haemorrhage and traumatic brain injury.
Healthcare educators and practitioners seeking guidelines, best practices, and recommendations for creating and managing cost-effective, researched-based simulation education and training programs now have a world class road map in the new textbook Defining Excellence in Simulation Programs.
The United Nations World Food Programme will phase out food aid and HIV/AIDS support to Uganda, a United Nations official said on Thursday, Xinhua/ChinaView.cn.com reports. The plan could affect more than 1.5 million people.
David Griggs, Ph.D., director of biology at Saint Louis University's Center for World Health & Medicine, has received a $1 million R01 grant from the National Institutes of Health to investigate the development of what could be a new class of drugs to treat bone diseases.
› Verified 2 days ago
Dr. Ju Kuang, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 17207 Kuykendahl Rd, Suite 200, Spring, TX 77379 Phone: 832-698-5320 | |
Dr. Olivia Quintos, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 17207 Kuykendahl Rd, Suite 200, Spring, TX 77379 Phone: 832-698-5320 | |
Dr. Soudip Saha, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 21227 Fernhollow Ln, Spring, TX 77388 Phone: 805-290-0129 | |
Dr. Hansa Mehta, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 17207 Kuykendahl Rd, Suite 200, Spring, TX 77379 Phone: 832-698-5320 | |
Dr. Timothy Osborn, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 17207 Kuykendahl Rd, Suite 200, Spring, TX 77379 Phone: 832-698-5320 | |
Dr. Roger Rankin, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 17207 Kuykendahl Rd, Suite 200, Spring, TX 77379 Phone: 832-698-5320 | |
Yo Jin Yoon, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 17207 Kuykendahl Rd Ste 220, Spring, TX 77379 Phone: 832-698-5331 |